Eye drops could replace needles for blinding eye disease?
Disease control
Completed
This early-stage trial tested the safety of SCAI-005, an eye drop containing axitinib, in 48 healthy Korean adults. The goal was to see if the drug is safe and how it behaves in the body when given as single or multiple doses. It is a first step toward a potential needle-free tre…
Phase: PHASE1 • Sponsor: SCAI Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 14:38 UTC